Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress

被引:97
作者
Katavetin, Pisut
Inagi, Reiko
Miyata, Toshio
Shao, Jing
Sassa, Ryoji
Adler, Stephen
Eto, Nobuaki
Kato, Hideki
Fujita, Toshiro
Nangaku, Masaomi [1 ]
机构
[1] Univ Tokyo, Sch Med, Div Nephrol & Endocrinol, Tokyo, Japan
[2] Tokai Univ, Sch Med, Inst Med Sci, Dept Med, Kanagawa, Japan
[3] Dept Hemodialysis Okazaki Kita Clin, Aichi, Japan
[4] New York Med Coll, Dept Med, Div Nephrol, Valhalla, NY 10595 USA
基金
日本学术振兴会;
关键词
renal endothelial cells; intracellular reactive oxygen species; chronic tubulointerstitial injury; renoprotection;
D O I
10.1016/j.bbrc.2007.05.207
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Recent studies have established that erythropoietin (EPO) is a pleiotropic cytokine. In this study we investigated whether pleiotropic effects of EPO may involve regulation of heme oxygenase (HO)-1, an anti-oxidative stress protein. A stimulatory effect of EPO on HO-1 expression was demonstrated in cultured renal endothelial cells, in which EPO decreased intracellular oxidative stress and provided cytoprotection against H2O2. These beneficial effects were partially reversed by a HO-1 inhibitor. We then evaluated whether EPO induces HO-1 and ameliorates renal injury in vivo. Administration of EPO to Dahl salt-sensitive (DS) rats with low salt diet, a model of chronic tubulointerstitial injury, reduced proteinuria, and renal injury including peritubular capillaries rarefaction as compared to vehicle-treated DS rats. This renoprotection was associated with up-regulation of HO-1 in the kidney. In conclusion, EPO-induced HO-1 expression is likely to provide cytoprotection against oxidative stress. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:928 / 934
页数:7
相关论文
共 21 条
[1]
ABRAHAM NG, 1989, EXP HEMATOL, V17, P908
[2]
ERYTHROPOIETIN RECEPTOR MESSENGER-RNA EXPRESSION IN HUMAN ENDOTHELIAL-CELLS [J].
ANAGNOSTOU, A ;
LIU, ZY ;
STEINER, M ;
CHIN, K ;
LEE, ES ;
KESSIMIAN, N ;
NOGUCHI, CT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) :3974-3978
[3]
Isolation of putative progenitor endothelial cells for angiogenesis [J].
Asahara, T ;
Murohara, T ;
Sullivan, A ;
Silver, M ;
vanderZee, R ;
Li, T ;
Witzenbichler, B ;
Schatteman, G ;
Isner, JM .
SCIENCE, 1997, 275 (5302) :964-967
[4]
Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure [J].
Bahlmann, FH ;
Song, R ;
Boehm, SM ;
Mengel, M ;
von Wasielewski, R ;
Lindschau, C ;
Kirsch, T ;
de Groot, K ;
Laudeley, R ;
Niemczyk, E ;
Güler, F ;
Menne, J ;
Haller, H ;
Fliser, D .
CIRCULATION, 2004, 110 (08) :1006-1012
[5]
Calò LA, 2003, INT J CLIN PHARM TH, V41, P187
[6]
Deshane J, 2005, ACTA BIOCHIM POL, V52, P273
[7]
Astroglial cytoprotection by erythropoietin pre-conditioning: implications for ischemic and degenerative CNS disorders [J].
Diaz, Z ;
Assaraf, MI ;
Miller, WH ;
Schipper, HM .
JOURNAL OF NEUROCHEMISTRY, 2005, 93 (02) :392-402
[8]
Reduced angiotensin II and oxidative stress contribute to impaired vasodilation in Dahl salt-sensitive rats on low-salt diet [J].
Drenjancevic-Peric, I ;
Lombard, JH .
HYPERTENSION, 2005, 45 (04) :687-691
[9]
Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse [J].
Galeano, M ;
Altavilla, D ;
Cucinotta, D ;
Russo, GT ;
Calò, M ;
Bitto, A ;
Marini, H ;
Marini, R ;
Adamo, EB ;
Seminara, P ;
Minutoli, L ;
Torre, V ;
Squadrito, F .
DIABETES, 2004, 53 (09) :2509-2517
[10]
HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration [J].
Grimm, C ;
Wenzel, A ;
Groszer, M ;
Mayser, H ;
Seeliger, M ;
Samardzija, M ;
Bauer, C ;
Gassmann, M ;
Remé, CE .
NATURE MEDICINE, 2002, 8 (07) :718-724